Weaning patients with acute kidney injury (AKI) from dialysis while they are still hospitalized may save them from remaining ...

This could be done if chronic conditions like diabetes, high blood pressure and high cholesterol levels were diagnosed early.

Vor Biopharma prices $100 million share offering as partner RemeGen reports strong Phase 3 results for telitacicept in IgA ...

Following President Xi Jinping's visits to Hainan and Guangdong, CGTN published an article on China's strategic priorities of high-standard opening up to drive high-quality growth. The piece outlines ...

In an eye-opening report released by PharmEasy ahead of World Diabetes Day, an analysis of over 4 million diagnostic reports ...

Humacyte, Inc. ( HUMA) Q3 2025 Earnings Call November 12, 2025 8:00 AM EST Good morning, ladies and gentlemen, and welcome to the Humacyte's Third Quarter Results Conference Call. [Operator ...

A mismatch between two common tests for kidney function may indicate a higher risk for kidney failure, heart disease, and ...

More patients with AKI recovered kidney function after a conservative hemodialysis strategy compared with patients on ...

Takeda Pharmaceutical Co. Ltd.’s anti-CD38 antibody, mezagitamab (TAK-079), sustained kidney function up to 18 months after ...

Researchers have uncovered and then overcome an obstacle that has led to the failure of pioneering efforts in ...

The results of two large-scale studies demonstrate that sodium-glucose co-transporter 2 (SGLT2) inhibitors significantly ...

The current kidney transplant waitlisting criterion is based on a single measurement of kidney function (estimated glomerular ...